4//SEC Filing
ALTSHULER DAVID 4
Accession 0000875320-25-000101
CIK 0000875320other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 4:04 PM ET
Size
6.1 KB
Accession
0000875320-25-000101
Insider Transaction Report
Form 4
ALTSHULER DAVID
Director
Transactions
- Tax Payment
Common Stock
2025-02-24$483.28/sh−3,971$1,919,105→ 41,048 total - Sale
Common Stock
2025-02-25$480.95/sh−848$407,846→ 40,200 total
Footnotes (1)
- [F1]Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1, which was entered into on 8/8/2024.
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeother
Related Parties
1- filerCIK 0001550395
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 4:04 PM ET
- Size
- 6.1 KB